February 15, 2006


Case Report

'White Spot' Draws Attention for 30 Years

Patient's 'white spot' is identified as astrocytic hamartoma after being undiagnosed for 30 years.

Humanitarian O.D.

Eye Care in the Tsunami's Aftermath

This optometrist aided victims on the southwest coast of Sri Lanka, one of the areas most devastated by the tsunami.

Patient Care

Does the 'Little Blue Pill' Cause Big Problems?

O.D.s must be aware of potential adverse ocular side effects of Viagra and other medications used to treat erectile dysfunction.

Practice Management

Bill Your Patients' Medical Insurance (the Right Way)

Learn the two most common mistakes that O.D.s make and why you should bill your patients' medical carrier.

Practitioner Care

Overcome Private-Practice Burnout

By acknowledging burnout, seeking help for it and making changes to your situation, you can beat this debilitating condition.



You Better Believe It!

'If you believe it, you can achieve it.' That's good advice for optometrists. Here's a short list of my beliefs. Now after writing it, I believe I'll take a nap.

Clinical Quandaries

How Serious is Central Serous?

After confirmation of the diagnosis, the optometrist can follow the majority of these patients.

Cornea and Contact Lens Q & A

Is PDT the Key to Ending CNV?

New research shows that novel PDT applications may stop CNV for good. But this treatment isn't standard... yet.

Diagnostic Quiz

Glaucoma Grand Rounds

The End of the Road

An elderly glaucoma patient has progressive vision loss despite aggressive therapy. How would you handle the situation?

Letters to the Editor

Meetings and Conferences

News Review


Optometry Needs Dr. Phil

I know optometrists have alot of bottled-up stress--even if you refuse to admit it.

Product Review

Retina Quiz

Fundus Changes Follow Trauma

Patient experiences visual field defects, temporal pallor and other changes to both optic nerves in the aftermath of a beating.

Therapeutic Review

Cyclosporine "Off-Label" Uses

When a patient fails to respond to conventional therapy, cyclosporine A may be the answer.